Wickham TJ - Search Results

1

Kovesdi I, Brough DE, Bruder JT, Wickham TJ. Kovesdi I, et al. Among authors: wickham tj. Curr Opin Biotechnol. 1997 Oct;8(5):583-9. doi: 10.1016/s0958-1669(97)80033-x. Curr Opin Biotechnol. 1997. PMID: 9353227 Review.

2

Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins.

Wickham TJ, Tzeng E, Shears LL 2nd, Roelvink PW, Li Y, Lee GM, Brough DE, Lizonova A, Kovesdi I. Wickham TJ, et al. J Virol. 1997 Nov;71(11):8221-9. doi: 10.1128/JVI.71.11.8221-8229.1997. J Virol. 1997. PMID: 9343173 Free PMC article.

3

Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types.

Wickham TJ, Roelvink PW, Brough DE, Kovesdi I. Wickham TJ, et al. Nat Biotechnol. 1996 Nov;14(11):1570-3. doi: 10.1038/nbt1196-1570. Nat Biotechnol. 1996. PMID: 9634823

4

Optimizing cardiovascular gene therapy: increased vascular gene transfer with modified adenoviral vectors.

Kibbe MR, Murdock A, Wickham T, Lizonova A, Kovesdi I, Nie S, Shears L, Billiar TR, Tzeng E. Kibbe MR, et al. Arch Surg. 2000 Feb;135(2):191-7. doi: 10.1001/archsurg.135.2.191. Arch Surg. 2000. PMID: 10668880

5

Adenovirus as a gene therapy vector for hematopoietic cells.

Marini FC 3rd, Yu Q, Wickham T, Kovesdi I, Andreeff M. Marini FC 3rd, et al. Cancer Gene Ther. 2000 Jun;7(6):816-25. doi: 10.1038/sj.cgt.7700174. Cancer Gene Ther. 2000. PMID: 10880011 Review.

6

Targeting of adenovirus penton base to new receptors through replacement of its RGD motif with other receptor-specific peptide motifs.

Wickham TJ, Carrion ME, Kovesdi I. Wickham TJ, et al. Gene Ther. 1995 Dec;2(10):750-6. Gene Ther. 1995. PMID: 8750015

7

Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies.

Wickham TJ, Segal DM, Roelvink PW, Carrion ME, Lizonova A, Lee GM, Kovesdi I. Wickham TJ, et al. J Virol. 1996 Oct;70(10):6831-8. doi: 10.1128/JVI.70.10.6831-6838.1996. J Virol. 1996. PMID: 8794324 Free PMC article.

8

Targeted adenovirus-mediated gene delivery to T cells via CD3.

Wickham TJ, Lee GM, Titus JA, Sconocchia G, Bakács T, Kovesdi I, Segal DM. Wickham TJ, et al. J Virol. 1997 Oct;71(10):7663-9. doi: 10.1128/JVI.71.10.7663-7669.1997. J Virol. 1997. PMID: 9311849 Free PMC article.

9

Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation.

Wickham TJ, Haskard D, Segal D, Kovesdi I. Wickham TJ, et al. Cancer Immunol Immunother. 1997 Nov-Dec;45(3-4):149-51. doi: 10.1007/s002620050419. Cancer Immunol Immunother. 1997. PMID: 9435860 Free PMC article.

10

The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F.

Roelvink PW, Lizonova A, Lee JG, Li Y, Bergelson JM, Finberg RW, Brough DE, Kovesdi I, Wickham TJ. Roelvink PW, et al. Among authors: wickham tj. J Virol. 1998 Oct;72(10):7909-15. doi: 10.1128/JVI.72.10.7909-7915.1998. J Virol. 1998. PMID: 9733828 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters